Uncovering the immunopeptidome of fibrolamellar cancer to expand the target repertoire for T cell-based immunotherapy development
Timeframe: 2025 – 2027 Goals: Assess the potential of a FLC therapeutic vaccine to prevent disease recurrence Principal Investigators: Jens Bauer, PhD Study Details: This study, led by Dr. Jens Bauer of the University Hospital Tübingen, aims to develop a new approach to improve the effectiveness of the anti-FLC vaccines that are under development in …